Platomics
Private Company
Total funding raised: $3M
Overview
Platomics operates at the intersection of AI/ML, genomics, and regulatory science, providing a software-as-a-service platform to streamline IVD compliance. Its core offering, the PlatoX® regulatory platform, helps labs and manufacturers efficiently generate the documentation required under regulations like the IVDR. By digitizing and automating these burdensome processes, Platomics aims to reduce compliance costs, prevent a reduction in diagnostic offerings, and ultimately speed up the delivery of advanced tests to patients. The company is ISO 13485 and 27001 certified, underscoring its commitment to quality and data security in the healthcare sector.
Technology Platform
PlatoX® regulatory platform: A software platform that automates and digitizes the generation of technical documentation and compliance workflows for in vitro diagnostics (IVD) under regulations like the EU IVDR.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Platomics competes in the regulatory technology (RegTech) niche for diagnostics. Competitors likely include large regulatory consulting firms (e.g., Emergo by UL, NSF) offering manual services and potentially developing software tools, as well as other specialized SaaS startups focusing on medical device or IVD compliance. Its differentiator is a dedicated platform combining software automation with targeted educational content for the IVD sector.